UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis

PloS one, 2023-01, Vol.18 (1), p.e0278262-e0278262

2023

Volltextzugriff (PDF)

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

Nature medicine, 2022-12, Vol.28 (12), p.2547-2554

2022

Volltextzugriff (PDF)

A predictive model to identify Parkinson disease from administrative claims data

Neurology, 2017-10, Vol.89 (14), p.1448

2017

Volltextzugriff (PDF)

55 Tracking Cognitive Change in Huntington’s Disease with the Mini Mental State Exam and the Montreal Cognitive Assessment

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.566-567

2023

Volltextzugriff (PDF)

Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson's disease

Aging, Neuropsychology, and Cognition, 2021-11, Vol.28 (6), p.812-828

2021

Volltextzugriff (PDF)

An Algorithm for Automated Measurement of Kinetic Tremor Magnitude Using Digital Spiral Drawings

Digital biomarkers, 2024-07, Vol.8 (1), p.140-148

2024

Volltextzugriff (PDF)

Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials

Frontiers in neurology, 2021-04, Vol.12, p.648532-648532

2021

Volltextzugriff (PDF)

Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures

Parkinsonism & related disorders, 2023-02, Vol.107, p.105272-105272, Article 105272

2023

Volltextzugriff (PDF)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

Annals of clinical and translational neurology, 2021-09, Vol.8 (9), p.1817-1830

2021

Volltextzugriff (PDF)

Continuous dopaminergic delivery to minimize motor complications in Parkinson's disease

Expert review of neurotherapeutics, 2013-06, Vol.13 (6), p.719-729

2013

Volltextzugriff (PDF)

Triggering essential head tremor with sustained phonation: A clinical phenomenon with potential diagnostic value

Parkinsonism & related disorders, 2014-02, Vol.20 (2), p.230-232

2014

Volltextzugriff (PDF)

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

Journal of clinical medicine, 2020-11, Vol.9 (11), p.3682

2020

Volltextzugriff (PDF)

Basal Ganglia Gliosis in a Case of Rapid‐Onset Dystonia‐Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3)

Movement disorders clinical practice (Hoboken, N.J.), 2016-11, Vol.3 (6), p.618-620

2016

Volltextzugriff (PDF)

Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine

Neurology, 2018-10, Vol.91 (17), p.797

2018

Volltextzugriff (PDF)

59 Preliminary Findings of Semantic Interference in Learning and Memory Processes in Manifest Huntington’s Disease

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.664-664

2023

Volltextzugriff (PDF)

Sa1470: REVISITING THE RISK OF TARDIVE DYSKINESIA WITH METOCLOPRAMIDE USE: A REAL-WORLD DATA DRIVEN EPIDEMIOLOGY STUDY FROM 2011-2021

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-386-S-386

2022

Volltextzugriff (PDF)

Longstanding Multiple System Atrophy-Parkinsonism with Limbic and FTLD-type α-Synuclein Pathology

Neuropathology and applied neurobiology, 2021-12, Vol.48 (3), p.e12783-e12783

2021

Volltextzugriff (PDF)

Long‐standing multiple system atrophy‐Parkinsonism with limbic and FTLD‐type α‐synuclein pathology

Neuropathology and applied neurobiology, 2022-04, Vol.48 (3), p.e12783-n/a

2022

Volltextzugriff (PDF)

CSF tau phosphorylation occupancy at t217 increases in MAPT R406W mutation carriers without amyloid pathology

Alzheimer's & dementia, 2021-12, Vol.17 (S5), p.n/a

2021

Volltextzugriff (PDF)

Cost of antibiotic beads is justified: a study of open fracture wounds and chronic osteomyelitis

Journal of long-term effects of medical implants, 2007, Vol.17 (3), p.181

2007

Volltextzugriff (PDF)

Tau kinetics in Alzheimer disease and primary tauopathies: Development of new models and analysis methods/tau

Alzheimer's & dementia, 2020-12, Vol.16 (S3)

2020

Volltextzugriff (PDF)

Tau kinetics in Alzheimer disease and primary tauopathies

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset

Movement disorders clinical practice (Hoboken, N.J.), 2021-01, Vol.8 (1), p.100-105

2021

Volltextzugriff (PDF)

Basal Ganglia Gliosis in a Case of Rapid‐Onset Dystonia‐Parkinsonism ( DYT 12) with a Novel Mutation in ATP ase 1A3 ( ATP 1A3 )

Movement disorders clinical practice (Hoboken, N.J.), 2016-11, Vol.3 (6), p.618-620

2016

Volltextzugriff (PDF)

Basal Ganglia Gliosis in a Case of Rapid-Onset Dystonia-Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3)

Movement disorders clinical practice, 2016, Vol.3 (6), p.618-620

2016

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)
Berichte
(2)
Reviews
(2)
Bücher
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

A predictive model to identify Parkinson disease from administrative claims data

55 Tracking Cognitive Change in Huntington’s Disease with the Mini Mental State Exam and the Montreal Cognitive Assessment

Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson's disease

An Algorithm for Automated Measurement of Kinetic Tremor Magnitude Using Digital Spiral Drawings

Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials

Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

Continuous dopaminergic delivery to minimize motor complications in Parkinson's disease

Triggering essential head tremor with sustained phonation: A clinical phenomenon with potential diagnostic value

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

Basal Ganglia Gliosis in a Case of Rapid‐Onset Dystonia‐Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3)

Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine

59 Preliminary Findings of Semantic Interference in Learning and Memory Processes in Manifest Huntington’s Disease

Sa1470: REVISITING THE RISK OF TARDIVE DYSKINESIA WITH METOCLOPRAMIDE USE: A REAL-WORLD DATA DRIVEN EPIDEMIOLOGY STUDY FROM 2011-2021

Longstanding Multiple System Atrophy-Parkinsonism with Limbic and FTLD-type α-Synuclein Pathology

Long‐standing multiple system atrophy‐Parkinsonism with limbic and FTLD‐type α‐synuclein pathology

CSF tau phosphorylation occupancy at t217 increases in MAPT R406W mutation carriers without amyloid pathology

Cost of antibiotic beads is justified: a study of open fracture wounds and chronic osteomyelitis

Tau kinetics in Alzheimer disease and primary tauopathies: Development of new models and analysis methods/tau

Tau kinetics in Alzheimer disease and primary tauopathies

Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset

Basal Ganglia Gliosis in a Case of Rapid‐Onset Dystonia‐Parkinsonism ( DYT 12) with a Novel Mutation in ATP ase 1A3 ( ATP 1A3 )

Basal Ganglia Gliosis in a Case of Rapid-Onset Dystonia-Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (ATP1A3)

Suchergebnisse filtern